Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/09/2025 ,inter alia, to consider and approve Dear Sir/ Madam, We ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its Board of Directors will meet on 25th September 2025 to consider a proposal for issuing equity shares and/or warrants through a preferential allotment route, under SEBI's ICDR Regulations and the Companies Act, 2013. The company has also declared a trading window closure starting from the date of this intimation until 48 hours after the board meeting concludes. The preferential issue will be subject to necessary regulatory and statutory approvals. No specific details on issue size, price, or allottees have been disclosed in this intimation.
For existing shareholders, a preferential allotment typically means dilution of their stake since shares or convertible warrants will be issued to select investors at a price determined by the board. This may put short-term pressure on the stock price, but the actual impact will depend on the issue price, size, and identity of the allottees, which are yet to be announced.